Quadmix, compounded by Olympia Pharmacy, Orlando, FL
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
💊
Drugs Recalls
Prescription and over-the-counter medications
17,685 Total Recalls
Detomidine w/Xylazine 100 mg/mg Injection, compounded by Olympia Pharmacy, Orlando, FL
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Pentosan 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Papaverine 40 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Methylcobalamin P 10/ml Creatine 40 mg/ml / Arginine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Aminocaproic Acid 0.5mg/ml Injection,compounded by Olympia Pharmacy, Orlando, FL
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Deslorelin 15 mg vial, compounded by Olympia Pharmacy, Orlando, FL
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Caco/Copper 6. 2 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Gentamicin 0.3% Injection, compounded by Olympia Pharmacy, Orlando, FL
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
L-ArGiNINE 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Furosemide 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Sodium Tetradecyl Sulfate (0.125%, 1%, 2.5%, 3%, and 4%) Injection, compounded by Olympia Pharmacy, Orlando, FL
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Clenbuterol 0.03mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Aminophylline 2.5% Injection, compounded by Olympia Pharmacy, Orlando, FL
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
BNP/Dexamethasone Eye Ointment, compounded by Olympia Pharmacy, Orlando, FL
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Iodine 20 mg Injection, compounded by Olympia Pharmacy, Orlando, FL
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Dexamethasone Sodium Phosphate 6 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Camila (norethindrone tablets, USP), 0.35 mg, 6 blister cards per carton, 28 tablets each, 28 day regimen, Rx Only, Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-0715-58
Teva Pharmaceuticals USA
Class I - Dangerous
Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing
Beta Alanine 100 mg/ml / l-carnosine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
HACC 270.1 Injection, compounded by Olympia Pharmacy, Orlando, FL
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Class I - Dangerous
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes